HI
STOK icon

Harbour Investments’s Stoke Therapeutics STOK Stock Holding History

Harbour Investments’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
4,413
+1,061
+32% +$34K ﹤0.01% 1787
2026
Q1 		$109K Buy
3,352
+2,167
+183% +$71.1K ﹤0.01% 1881
2025
Q4 		$37.6K Buy
1,185
+898
+313% +$27K ﹤0.01% 2098
2025
Q3 		$6.75K Buy
287
+237
+474% +$4.06K ﹤0.01% 2863
2025
Q2 		$568 Hold
50
– – ﹤0.01% 3353
2025
Q1 		$333 Hold
50
– – ﹤0.01% 3383
2024
Q4 		$552 Hold
50
– – ﹤0.01% 3268
2024
Q3 		$615 Hold
50
– – ﹤0.01% 3172
2024
Q2 		$676 Buy
+50
New +$675 ﹤0.01% 3050

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Harbour Investments's STOK Position: Q2 2026 in Review

Harbour Investments increased its Stoke Therapeutics (STOK) stake by 32% in Q2 2026, buying an estimated $34K and bringing the position to 4,413 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Harbour Investments first reported a position in STOK in Q2 2024 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Harbour Investments held 4,413 shares of Stoke Therapeutics worth $144K as of Q2 2026.
  • Harbour Investments bought 1,061 Stoke Therapeutics shares in Q2 2026, an estimated $34K.
  • Stoke Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1787 holding.
  • Harbour Investments first reported a position in Stoke Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.